RaySearch Laboratories AB Class B RAY B
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 147.60
- Day Range
- SEK 148.00–155.00
- 52-Week Range
- SEK 55.60–155.00
- Bid/Ask
- SEK 148.40 / SEK 148.80
- Market Cap
- SEK 5.09 Bil
- Volume/Avg
- 81,355 / 73,790
Key Statistics
- Price/Earnings (Normalized)
- 50.13
- Price/Sales
- 4.82
- Dividend Yield (Trailing)
- 0.47%
- Dividend Yield (Forward)
- 0.47%
- Total Yield
- 0.47%
Company Profile
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia, Europe and the rest of the world. The company generates majority of its sales from the North America.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 388
- Website
- https://www.raysearchlabs.com
Comparables
Valuation
|
Metric
|
RAY B
|
AKEL D
|
IVSO
|
|---|---|---|---|
Price/Earnings (Normalized) | 50.13 | 162.64 | 64.05 |
Price/Book Value | 6.52 | 2.99 | 13.84 |
Price/Sales | 4.82 | 29.94 | 8.92 |
Price/Cash Flow | 12.76 | 78.06 | 44.47 |
Price/Earnings
RAY B
AKEL D
IVSO
Financial Strength
|
Metric
|
RAY B
|
AKEL D
|
IVSO
|
|---|---|---|---|
Quick Ratio | 1.19 | 0.13 | 2.11 |
Current Ratio | 1.21 | 0.15 | 3.12 |
Interest Coverage | 47.31 | −2.40 | — |
Quick Ratio
RAY B
AKEL D
IVSO
Profitability
|
Metric
|
RAY B
|
AKEL D
|
IVSO
|
|---|---|---|---|
Return on Assets (Normalized) | 5.21% | −4.95% | 15.27% |
Return on Equity (Normalized) | 14.05% | −10.14% | 22.30% |
Return on Invested Capital (Normalized) | 8.29% | −4.86% | 20.82% |
Return on Assets
RAY B
AKEL D
IVSO
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Zvfrq | $35.6 Bil | |
VEEV
| Veeva Systems Inc Class A | Qyxrbfgsn | Dvfld | $28.2 Bil | |
SOLV
| Solventum Corp | — | Rfwmqrq | $10.2 Bil | |
PMCUF
| Pro Medicus Ltd | — | Qqskty | $8.3 Bil | |
HQY
| HealthEquity Inc | — | Bxjxqy | $6.8 Bil | |
MTHRF
| M3 Inc | — | Fnxvv | $6.6 Bil | |
MTHRY
| M3 Inc ADR | — | Zyqtjx | $6.6 Bil | |
RCM
| R1 RCM Inc | — | Hmj | $5.4 Bil | |
DOCS
| Doximity Inc Class A | — | Ynkxj | $5.3 Bil | |
TXG
| 10x Genomics Inc Ordinary Shares - Class A | — | Cfxm | $2.7 Bil |